NEUROPHET Statistics

Total Valuation

NEUROPHET has a market cap or net worth of KRW 160.10 billion. The enterprise value is 141.88 billion.

Market Cap	160.10B
Enterprise Value	141.88B

Important Dates

The next estimated earnings date is Thursday, June 18, 2026.

Earnings Date	Jun 18, 2026
Ex-Dividend Date	n/a

Share Statistics

NEUROPHET has 12.09 million shares outstanding.

Current Share Class	12.09M
Shares Outstanding	12.09M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+78.90%
Owned by Insiders (%)	39.89%
Owned by Institutions (%)	10.93%
Float	6.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	62.48
PB Ratio	8.43
P/TBV Ratio	8.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.09
EV / Sales	55.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.72

Financial Position

The company has a current ratio of 8.04, with a Debt / Equity ratio of 0.03.

Current Ratio	8.04
Quick Ratio	7.84
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-44.03

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-91.23%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	19,284.80
200-Day Moving Average	21,280.60
Relative Strength Index (RSI)	28.51
Average Volume (20 Days)	479,554

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NEUROPHET had revenue of KRW 2.56 billion and -23.30 billion in losses. Loss per share was -2,109.07.

Revenue	2.56B
Gross Profit	2.57B
Operating Income	-17.77B
Pretax Income	-23.30B
Net Income	-23.30B
EBITDA	-16.64B
EBIT	-17.77B
Loss Per Share	-2,109.07

Full Income Statement

Balance Sheet

The company has 18.74 billion in cash and 524.40 million in debt, with a net cash position of 18.21 billion or 1,506.33 per share.

Cash & Cash Equivalents	18.74B
Total Debt	524.40M
Net Cash	18.21B
Net Cash Per Share	1,506.33
Equity (Book Value)	18.99B
Book Value Per Share	1,587.92
Working Capital	17.50B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.71 billion and capital expenditures -571.39 million, giving a free cash flow of -16.28 billion.

Operating Cash Flow	-15.71B
Capital Expenditures	-571.39M
Depreciation & Amortization	1.13B
Net Borrowing	-640.57M
Free Cash Flow	-16.28B
FCF Per Share	-1,346.31

Full Cash Flow Statement

Margins

Gross Margin	100.21%
Operating Margin	-693.52%
Pretax Margin	-909.17%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NEUROPHET does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-14.55%
FCF Yield	-10.17%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NEUROPHET has an Altman Z-Score of 44.31 and a Piotroski F-Score of 1.

Altman Z-Score	44.31
Piotroski F-Score	1